Leap Investments’s Dermira, Inc. DERM Stock Holding History

Leap Investments’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-25,300	Closed	-$242K	–	557
2019 Q2	$242K	Buy	+25,300	New	+$272K	0.33%	123

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Leap Investments's DERM Position: Q3 2019 in Review

Leap Investments sold out of Dermira, Inc. (DERM) in Q3 2019, closing a stake of 25,300 shares — an estimated $242K sold.

Leap Investments first reported a position in DERM in Q2 2019 and held it in 1 quarter. The position peaked at $242K in Q2 2019. 131 funds tracked by Wall St. Rank hold DERM as of Q3 2019.

Leap Investments reported no remaining Dermira, Inc. position as of Q3 2019 after selling out during the quarter.
Leap Investments sold 25,300 Dermira, Inc. shares in Q3 2019, an estimated $242K.
Leap Investments first reported a position in Dermira, Inc. in Q2 2019 and held it in 1 quarter.
Leap Investments's Dermira, Inc. position peaked at $242K in Q2 2019.
131 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2019.

Based on Leap Investments's 13F filing for Q3 2019, filed 13 Nov 2019.